专利号:US-2021062179-A1 优先权日:2015-02-26 标题 :Microsomal bioreactor for synthesis of drug metabolites 发明人:KRISHNAN SADAGOPAN; WALGAMA CHARUKSHA THAMEERA; NERIMETLA RAJASEKHARA REDDY 权利人:UNIV OKLAHOMA STATE 摘要:Reusable microsomal biocatalytic systems (bioreactors) constructed on carbon nanostructure modified electrodes are provided. The bioreactors comprise stable, biologically active immobilized enzymes such as human cytochromes P 450 (CYPs) and their redox partner proteins, e.g. CYP-NADPH (reduced nicotinamide adenine dinucleotide phosphate) reductases (CPR), on the carbon nanostructure surface. The immobilized enzymes may be present in liver microsomes, such as human liver microsomes (HLM) or as bactosomes, S9 fractions, etc. The bioreactors are used, for example, for synthesizing metabolites of interest from compounds such as drugs that are catabolized by the enzymes.
专利号:US-2018044657-A1 优先权日:2015-02-26 标 题 :Microsomal bioreactor for synthesis of drug metabolites
专利号:WO-2016138477-A1 优先权日:2015-02-26 标题:Microsomal bioreactor for synthesis of drug metabolites
[参考文献]: Astrid Jordet Langhammer, Et Al. Fennel And Raspberry Leaf As Possible Inhibitors Of Acetaminophen Oxidation. Phytother Res. 2014 Oct;28(10):1573-6. [参考文献]: Dany Spaggiari, Et Al. Comparison Of Liquid Chromatography And Supercritical Fluid Chromatography Coupled To Compact Single Quadrupole Mass Spectrometer For Targeted In Vitro Metabolism Assay. J Chromatogr A. 2014 Dec 5:1371:244-56. [参考文献]: Hsien-Tsung Yao, Et Al. Effect Of Commercially Available Green And Black Tea Beverages On Drug-Metabolizing Enzymes And Oxidative Stress In Wistar Rats. Food Chem Toxicol. 2014 Aug:70:120-7. [参考文献]: Jang Su Jeon, Et Al. Metabolic Characterization Of Meso-Dihydroguaiaretic Acid In Liver Microsomes And In Mice. Food Chem Toxicol. 2015 Feb:76:94-102. [参考文献]: Julia Dinger, Et Al. Development Of An In Vitro Cytochrome P450 Cocktail Inhibition Assay For Assessing The Inhibition Risk Of Drugs Of Abuse. Toxicol Lett. 2014 Oct 1;230(1):28-35.
合成参考文献
参考文献:10.1191/096032701680350587 摘要:Loizou GD, Cocker J. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone. Hum Exp Toxicol. 2001 Jul;20(7):321–7. doi: 10.1191/096032701680350587. 参考文献:10.1124/dmd.32.6.647 摘要:Walsky RL, Obach RS. Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 2004 Jun;32(6):647–60. doi: 10.1124/dmd.32.6.647. 参考文献:10.1124/dmd.107.017442 摘要:Ahn CY, Bae SK, Jung YS, Lee I, Kim YC, Lee MG, Shin WG. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus. Drug Metab Dispos. 2008 Jul;36(7):1233–41. doi: 10.1124/dmd.107.017442. 参考文献:10.1111/bph.14776 摘要:Trousil S, Lee P, Edwards RJ, Maslen L, Lozan‐Kuehne JP, Ramaswami R, Aboagye EO, Clarke S, Liddle C, Sharma R. Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation. British J Pharmacology. 2019 Aug 05;176(18):3712–22. doi: 10.1111/bph.14776. 参考文献:10.1016/j.lfs.2006.07.016 摘要:Kim YC, Lee I, Kim SG, Ko SH, Lee MG, Kim SH. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h. Life Sci. 2006 Nov 02;79(23):2179–86. doi: 10.1016/j.lfs.2006.07.016.